• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸膜肺炎放线杆菌:毒力和发病机制的分子决定因素。

Actinobacillus pleuropneumoniae: The molecular determinants of virulence and pathogenesis.

机构信息

Institute for Glycomics, Griffith University, Gold Coast, QLD, Australia.

Queensland Alliance for Agriculture and Food Innovation, The University of Queensland, St. Lucia, QLD, Australia.

出版信息

Adv Microb Physiol. 2021;78:179-216. doi: 10.1016/bs.ampbs.2020.12.001. Epub 2021 Jan 25.

DOI:10.1016/bs.ampbs.2020.12.001
PMID:34147185
Abstract

Actinobacillus pleuropneumoniae, the causative agent of porcine pleuropneumonia, is responsible for high economic losses in swine herds across the globe. Pleuropneumonia is characterized by severe respiratory distress and high mortality. The knowledge about the interaction between bacterium and host within the porcine respiratory tract has improved significantly in recent years. A. pleuropneumoniae expresses multiple virulence factors, which are required for colonization, immune clearance, and tissue damage. Although vaccines are used to protect swine herds against A. pleuropneumoniae infection, they do not offer complete coverage, and often only protect against the serovar, or serovars, used to prepare the vaccine. This review will summarize the role of individual A. pleuropneumoniae virulence factors that are required during key stages of pathogenesis and disease progression, and highlight progress made toward developing effective and broadly protective vaccines against an organism of great importance to global agriculture and food production.

摘要

猪传染性胸膜肺炎放线杆菌,引起猪传染性胸膜肺炎的病原体,是导致全球猪群经济损失的主要原因。传染性胸膜肺炎的特征是严重的呼吸困难和高死亡率。近年来,人们对猪呼吸道内细菌与宿主相互作用的认识有了显著提高。猪传染性胸膜肺炎放线杆菌表达多种毒力因子,这些毒力因子对于定植、免疫清除和组织损伤是必需的。尽管疫苗被用于保护猪群免受猪传染性胸膜肺炎放线杆菌感染,但它们不能提供完全的保护,而且通常仅能针对用于制备疫苗的血清型或血清型提供保护。本综述将总结在发病机制和疾病进展的关键阶段需要的单个猪传染性胸膜肺炎放线杆菌毒力因子的作用,并强调在开发针对这种对全球农业和食品生产具有重要意义的病原体的有效和广泛保护疫苗方面所取得的进展。

相似文献

1
Actinobacillus pleuropneumoniae: The molecular determinants of virulence and pathogenesis.胸膜肺炎放线杆菌:毒力和发病机制的分子决定因素。
Adv Microb Physiol. 2021;78:179-216. doi: 10.1016/bs.ampbs.2020.12.001. Epub 2021 Jan 25.
2
New trends in innovative vaccine development against Actinobacillus pleuropneumoniae.创新疫苗研制对抗胸膜肺炎放线杆菌的新趋势。
Vet Microbiol. 2018 Apr;217:66-75. doi: 10.1016/j.vetmic.2018.02.028. Epub 2018 Mar 6.
3
Actinobacillus pleuropneumoniae biofilms: Role in pathogenicity and potential impact for vaccination development.胸膜肺炎放线杆菌生物被膜:在致病性中的作用及对疫苗开发的潜在影响
Anim Health Res Rev. 2018 Jun;19(1):17-30. doi: 10.1017/S146625231700010X. Epub 2017 Nov 7.
4
Actinobacillus pleuropneumoniae vaccines: from bacterins to new insights into vaccination strategies.猪胸膜肺炎放线杆菌疫苗:从菌苗到疫苗接种策略的新见解
Anim Health Res Rev. 2008 Jun;9(1):25-45. doi: 10.1017/S1466252307001338. Epub 2008 Mar 17.
5
Actinobacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity.胸膜肺炎放线杆菌表面多糖:它们在诊断和免疫原性中的作用。
Anim Health Res Rev. 2000 Dec;1(2):73-93. doi: 10.1017/s1466252300000074.
6
Adhesion protein ApfA of Actinobacillus pleuropneumoniae is required for pathogenesis and is a potential target for vaccine development.猪胸膜肺炎放线杆菌的黏附蛋白ApfA是发病机制所必需的,并且是疫苗开发的潜在靶点。
Clin Vaccine Immunol. 2013 Feb;20(2):287-94. doi: 10.1128/CVI.00616-12. Epub 2012 Dec 26.
7
Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs.在猪中通过口服表达Apx毒素的酿酒酵母诱导针对胸膜肺炎放线杆菌攻击的保护性免疫反应。
Vet Immunol Immunopathol. 2013 Jan 15;151(1-2):132-9. doi: 10.1016/j.vetimm.2012.11.003. Epub 2012 Nov 9.
8
Attenuated Actinobacillus pleuropneumoniae double-deletion mutant S-8∆clpP/apxIIC confers protection against homologous or heterologous strain challenge.减毒胸膜肺炎放线杆菌双缺失突变体S-8∆clpP/apxIIC可抵御同源或异源菌株的攻击。
BMC Vet Res. 2017 Jan 6;13(1):14. doi: 10.1186/s12917-016-0928-9.
9
Nasal immunization with major epitope-containing ApxIIA toxin fragment induces protective immunity against challenge infection with Actinobacillus pleuropneumoniae in a murine model.在小鼠模型中,用含主要表位的ApxIIA毒素片段进行鼻腔免疫可诱导针对胸膜肺炎放线杆菌攻击感染的保护性免疫。
Vet Immunol Immunopathol. 2013 Jan 15;151(1-2):102-12. doi: 10.1016/j.vetimm.2012.10.011. Epub 2012 Nov 9.
10
[Construction and characterization of Actinobacillus pleuropneumoniae serovar 7 live attenuated vaccine strain co-expressing ApxIA].[共表达ApxIA的胸膜肺炎放线杆菌7型活疫苗株的构建与鉴定]
Sheng Wu Gong Cheng Xue Bao. 2010 Mar;26(3):305-10.

引用本文的文献

1
Evaluating the Immunogenic Potential of ApxI and ApxII from : An Immunoinformatics-Driven Study on mRNA Candidates.评估来自[具体来源未给出]的ApxI和ApxII的免疫原性潜力:一项基于免疫信息学的mRNA候选物研究
Vet Sci. 2025 Apr 27;12(5):414. doi: 10.3390/vetsci12050414.
2
The Arms Race Between Actinobacillus pleuropneumoniae and Its Genetic Environment: A Comprehensive Analysis of Its Defensome and Mobile Genetic Elements.胸膜肺炎放线杆菌与其遗传环境之间的军备竞赛:对其防御组和可移动遗传元件的综合分析
Mol Microbiol. 2025 Jul;124(1):40-53. doi: 10.1111/mmi.15374. Epub 2025 May 3.
3
Susceptibility evaluation and PK/PD integration of tulathromycin against during the mutant selection window.
在突变选择窗期间,泰拉霉素的敏感性评估及药代动力学/药效学整合
Front Vet Sci. 2024 Jul 3;11:1407907. doi: 10.3389/fvets.2024.1407907. eCollection 2024.
4
Naringin attenuates Actinobacillus pleuropneumoniae-induced acute lung injury via MAPK/NF-κB and Keap1/Nrf2/HO-1 pathway.柚皮苷通过 MAPK/NF-κB 和 Keap1/Nrf2/HO-1 通路减轻胸膜肺炎放线杆菌诱导的急性肺损伤。
BMC Vet Res. 2024 May 17;20(1):204. doi: 10.1186/s12917-024-04055-2.
5
Serotype diversity and antimicrobial susceptibility profiles of Actinobacillus pleuropneumoniae isolated in Italian pig farms from 2015 to 2022.2015 年至 2022 年意大利猪场分离的胸膜肺炎放线杆菌血清型多样性及抗菌药物敏感性分析。
Vet Res. 2024 Apr 9;55(1):48. doi: 10.1186/s13567-024-01305-x.
6
Examination of the Virulence of Serovar 16 in Pigs.猪血清型16毒力检测
Vet Sci. 2024 Feb 1;11(2):62. doi: 10.3390/vetsci11020062.
7
Intranasal B5 promotes mucosal defence against Actinobacillus pleuropneumoniae via ameliorating early immunosuppression.经鼻给予 B5 可通过改善早期免疫抑制来促进黏膜防御胸膜肺炎放线杆菌。
Virulence. 2024 Dec;15(1):2316459. doi: 10.1080/21505594.2024.2316459. Epub 2024 Feb 20.
8
Naringin's Alleviation of the Inflammatory Response Caused by by Downregulating the NF-κB/NLRP3 Signalling Pathway.柚皮苷通过下调 NF-κB/NLRP3 信号通路缓解 引起的炎症反应。
Int J Mol Sci. 2024 Jan 14;25(2):1027. doi: 10.3390/ijms25021027.
9
A physiologically based pharmacokinetic model to optimize the dosage regimen and withdrawal time of cefquinome in pigs.建立生理药代动力学模型优化头孢喹肟在猪体内的给药方案和停药期。
PLoS Comput Biol. 2023 Aug 16;19(8):e1011331. doi: 10.1371/journal.pcbi.1011331. eCollection 2023 Aug.
10
Actinobacillus pleuropneumoniae encodes multiple phase-variable DNA methyltransferases that control distinct phasevarions.胸膜肺炎放线杆菌编码多个相变异 DNA 甲基转移酶,这些酶控制不同的相变异。
Nucleic Acids Res. 2023 Apr 24;51(7):3240-3260. doi: 10.1093/nar/gkad091.